Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds (IM)
This study has been completed.
Children's Miracle Network
Information provided by (Responsible Party):
Lavjay Butani, MD, University of California, Davis
First received: February 4, 2008
Last updated: November 22, 2012
Last verified: November 2012
The purpose of this study is to determine if there are signs of inflammation in one's blood and urine and to find out if one's body size or ethnicity has an effect on these substances.
||Time Perspective: Cross-Sectional
||Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds
Primary Outcome Measures:
- To compare plasma levels of inflammatory markers and urinary biomarkers of oxidative stress in adolescents of Hispanic, African-American and Caucasian ethnicity [ Time Frame: at the end of study ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Secondary Outcome Measures:
- To determine if there is an independent correlation between these markers and urinary microalbumin excretion [ Time Frame: at the end of study ] [ Designated as safety issue: No ]
Aliquots from the citrate vial & Serum seperator vial are being retained
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||October 2009 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||12 Years to 18 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
pediatric out-patient at UCDavis Medical Center clinic
- Adolescents between 12 to 18 years old
- Hispanic, African American or Caucasian ethnicity
- Have a Body Mass Index (BMI) between the 5th and 85th percentile or greater than the 95th percentile
- Must currently be attending a UC Davis Pediatric clinic
- Chronic liver or kidney disease, known Diabetes or other chronic illnesses (such as Sickle Cell Disease or Cystic Fibrosis)
- Subjects can NOT be acutely febrile, smoke, chronically use prescription medications or oral contraceptive pills.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00616707
|UC Davis Medical Center
|Sacramento, California, United States, 95817 |
University of California, Davis
Children's Miracle Network
||Lavjay Butani, M.D.
||University of California, Davis
No publications provided
||Lavjay Butani, MD, Associate Professor, University of California, Davis
History of Changes
|Other Study ID Numbers:
|Study First Received:
||February 4, 2008
||November 22, 2012
||United States: Institutional Review Board
Keywords provided by University of California, Davis:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 31, 2015